Hartmut Issel, Head-APAC Equity at UBS Global Wealth Management, said that Indian pharma sector could face some risk if the US decides to place tariffs on specific types of medicines.
Hartmut Issel, Head-APAC Equity at UBS Global Wealth Management, said that Indian pharma sector could face some risk if the US decides to place tariffs on specific types of medicines.